Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Chan

Lupus

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Lupus|April 5, 2005
Lupus nephritis: induction therapyT M Chan
Lupus|July 16, 2008
Mycophenolate mofetil in the treatment of lupus nephritis--7 years onT M Chan
Lupus|February 13, 2019
Infectious complications in lupus nephritis treatment: a systematic review and meta-analysisK M Thong, T M Chan
Lupus|May 26, 1999
Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosusC C Mok, C S Lau, T M Chan, et al.
Lupus|August 8, 2015
Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritisD Y H Yap, S Yung, Q Zhang, et al.
Lupus|July 13, 2006
Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritisK C Tse, C S O Tang, W I Lio, et al.
Lupus|May 4, 2005
Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprineT M Chan, K C Tse, C S O Tang, et al.
Lupus|April 17, 2008
Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 miceS L Lui, S Yung, R Tsang, et al.
Lupus|February 8, 2007
A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockadeK C Tse, M F Lam, S C W Tang, et al.
Lupus|June 29, 2014
Myelitis in systemic lupus erythematosus frequently manifests as longitudinal and sometimes occurs at low disease activityX-Y Li, P Xiao, H-B Xiao, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Lupus|April 5, 2005
Lupus nephritis: induction therapyT M Chan
Lupus|July 16, 2008
Mycophenolate mofetil in the treatment of lupus nephritis--7 years onT M Chan
Lupus|February 13, 2019
Infectious complications in lupus nephritis treatment: a systematic review and meta-analysisK M Thong, T M Chan
Lupus|May 26, 1999
Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosusC C Mok, C S Lau, T M Chan, et al.
Lupus|August 8, 2015
Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritisD Y H Yap, S Yung, Q Zhang, et al.
Lupus|July 13, 2006
Quality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritisK C Tse, C S O Tang, W I Lio, et al.
Lupus|May 4, 2005
Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprineT M Chan, K C Tse, C S O Tang, et al.
Lupus|April 17, 2008
Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 miceS L Lui, S Yung, R Tsang, et al.
Lupus|February 8, 2007
A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockadeK C Tse, M F Lam, S C W Tang, et al.
Lupus|June 29, 2014
Myelitis in systemic lupus erythematosus frequently manifests as longitudinal and sometimes occurs at low disease activityX-Y Li, P Xiao, H-B Xiao, et al.
Pageof 2